News Release

New chemical imaging technique could help in the fight against atherosclerosis, suggests research

A new chemical imaging technique could one day help in the fight against atherosclerosis, suggests research published in the August 2009 edition of the Journal of the Royal Society Interface

Peer-Reviewed Publication

Imperial College London

A new chemical imaging technique could one day help in the fight against atherosclerosis, suggests research published in the August 2009 edition of the Journal of the Royal Society Interface.

Atherosclerosis is the disease underlying most heart attacks and strokes and it is characterised by lesions in the arteries, made of fats, collagen and cells. The lesions cause artery walls to harden and thicken, which severely restricts the flow of blood around the body and they can also rupture, leading to heart attacks and strokes. Understanding the precise chemical composition of an individual's lesions is important because the ones with higher levels of a type of fat called cholesteryl ester are more prone to rupture.

The team behind the new imaging technique, which is known as Attenuated Total Reflection Fourier Transform Infrared Spectroscopic Imaging (ATR-FTIR imaging), believe that with further refinement, it could become a useful tool for doctors wanting to assess a patient's lesions. For example, by combining fibre optic technology with ATR-FTIR imaging, the researchers believe doctors could carry out real-time inspections of patients with atherosclerosis, in order to assess the progress of the disease and establish which patients are at the greatest risk of complications.

Currently, doctors can use ultrasound to assess the size and location of lesions but they need to take biopsies of lesions in order to determine their chemistry. This is a complex and invasive procedure.

The researchers say the ATR-FTIR imaging could potentially improve current imaging techniques because it could combine imaging and chemical analysis, which would provide a comprehensive and accurate picture of a patient's lesions in one procedure. In the present study, the researchers demonstrated that ATR-FTIR imaging was able to reveal the precise composition and size of the lesions and the levels of elastin, collagen and cholesteryl ester in them.

The ATR-FTIR imaging technology works by using infrared light to identify different chemical molecules, which are mapped by an array detector to create a 'chemical photograph'.

The researchers used the technique to study the effects of age and an amino acid called L-arginine on the composition of lesions in cholesterol-fed rabbits. The work appeared to confirm that dietary L-arginine can remove lesions in the arteries of mature rabbits.

The researchers say further studies need to be done before the ATR-FTIR imaging could be used for patient care.

Lead-author, Professor Sergei Kazarian, from the Department of Chemical Engineering and Chemical Technology at Imperial College London, says:

"Atherosclerosis can be a dangerous condition and our hope is that with further work, our approaches could ultimately be used to determine which patients are most at risk of complications. That way, doctors can target treatments at those patients who most need it, in order to prevent strokes and heart attacks."

###

This research was funded by the Engineering and Physical Sciences Research Council.

For further information please contact:

Colin Smith
Press Officer
Imperial College London
Email: cd.smith@imperial.ac.uk
Tel: +44 (0)207 594 6712
Out of hours duty press officer: +44 (0)7803 886 248

Notes to editors:

(1) "Application of Fourier transform infrared spectroscopic imaging to the study of effects of age and dietary L-arginine on aortic lesion composition in cholesterol fed rabbits" Journal of the Royal Society, Interface, (Published the August 2009 edition).

The full listing of authors and their affiliations for this paper is as follows:

Francesca Palombo 1, Stephanie G. Cremers 2, Peter D. Weinburg 2, Sergei Kazarian 1

1 Department of Chemical Engineering and Chemical Technology, Imperial College London, SW7 2AZ, UK

2 Department of Bioengineering, Imperial College London, SW7 2AZ, UK,

The following funding acknowledgements from the authors appear at the end of the paper:

2. About Imperial College London

Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 13,000 students and 6,000 staff of the highest international quality.

Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.

Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve health in the UK and globally, tackle climate change and develop clean and sustainable sources of energy.

Website: www.imperial.ac.uk


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.